Tectonic Therapeutic (TECX) Tax Provisions (2024 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Tax Provisions of $254000.0 for Q4 2025, down 73.98% quarter-over-quarter from $976000.0 in Q2 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Tax Provisions (2024 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Tax Provisions for 1 consecutive years, with $254000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions changed N/A year-over-year to $254000.0; the TTM figure through Dec 2025 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
- Tax Provisions eased to $254000.0 in Q4 2025 per TECX's latest filing, from $976000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $976000.0 in Q2 2025 and bottomed at $254000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Tectonic Therapeutic | 583.14 Mn | 583.14 Mn | - | 77,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77,000.00 |
| Dec 31, 2025 | -16.29 Mn |
| Jun 30, 2025 | 976,000.00 |
| Dec 31, 2024 | -12.18 Mn |